Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1992 Jun;156(6):624–627.

Hepatitis A outbreak in Anchorage, Alaska, traced to ice slush beverages.

M Beller 1
PMCID: PMC1003348  PMID: 1319626

Abstract

The Alaska Department of Health and Social Services investigated a community outbreak of hepatitis A in Anchorage. A total of 57 persons who had hepatitis A between June and September 1988 were studied. Patients ranged from 1 to 54 years of age. A market was implicated as the source of the outbreak. An employee who prepared beverage mixtures in a bathroom was a contact of a person who had had hepatitis A 2 months before the outbreak; the employee was reported to have been jaundiced 3 to 4 weeks before the peak of the outbreak. The administration of immune globulin had an efficacy of 100% (95% confidence limits 69, 100%) in preventing hepatitis A among household contacts of primary cases. Similar beverages are sold by convenience markets and many other businesses nationwide. It is important to ensure that safe food-handling practices are followed by such establishments.

Full text

PDF
624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHLEY A. Gamma globulin; effect on secondary attack rates in infectious hepatitis. N Engl J Med. 1954 Mar 11;250(10):412–417. doi: 10.1056/NEJM195403112501003. [DOI] [PubMed] [Google Scholar]
  2. BROOKS B. F., HSIA D. Y., GELLIS S. S. Family outbreaks of infectious hepatitis; prophylactic use of gamma globulin. N Engl J Med. 1953 Jul 9;249(2):58–61. doi: 10.1056/NEJM195307092490202. [DOI] [PubMed] [Google Scholar]
  3. Bowen G. S., McCarthy M. A. Hepatitis A associated with a hardware store water fountain and a contaminated well in Lancaster County, Pennsylvania, 1980. Am J Epidemiol. 1983 Jun;117(6):695–705. doi: 10.1093/oxfordjournals.aje.a113603. [DOI] [PubMed] [Google Scholar]
  4. HSIA D. Y., LONSWAY M., Jr, GELLIS S. S. Gamma globulin in the prevention of infectious hepatitis; studies on the use of small doses in family outbreaks. N Engl J Med. 1954 Mar 11;250(10):417–419. doi: 10.1056/NEJM195403112501004. [DOI] [PubMed] [Google Scholar]
  5. Landrigan P. J., Huber D. H., Murphy G. D., 3rd, Creech W. B., Bryan J. A. The protective efficacy of immune serum globulin in hepatitis A: a statistical approach. JAMA. 1973 Jan 1;223(1):74–75. [PubMed] [Google Scholar]
  6. NOBLE H. B., PETERSON D. R. EVALUATION OF IMMUNE SERUM GLOBULIN FOR CONTROL OF INFECTIOUS HEPATITIS. Public Health Rep. 1965 Feb;80:173–177. [PMC free article] [PubMed] [Google Scholar]
  7. Orenstein W. A., Bernier R. H., Dondero T. J., Hinman A. R., Marks J. S., Bart K. J., Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055–1068. [PMC free article] [PubMed] [Google Scholar]
  8. Storch G., McFarland L. M., Kelso K., Heilman C. J., Caraway C. T. Viral hepatitis associated with day-care centers. JAMA. 1979 Oct 5;242(14):1514–1518. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES